Product Information
BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.2146 per EA under NDC 68462087801. Its NADAC has been published 235 times since Feb 23, 2022.
FDA first approved this application on Jan 26, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB
Bisoprolol Fumarate and HydrochlorothiazideStrength
2.5; 6.25 mg/1; mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462087801
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215995FDA Approved
1/26/2022
TE Code
AB
On Market Since
1/26/2022
Pharmacological Classes
Price Statistics
The NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB has been published 235 times since Feb 23, 2022, and over the history we have for it it has declined 35.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2146 per EA |
|---|---|
| All-time high | $0.3901 (May 11, 2022) |
| All-time low | $0.1729 (Nov 20, 2024) |
| 52-week high | $0.2146 |
| 52-week low | $0.1855 |
| Median price | $0.2370 |
| Average price | $0.2510 |
| Largest weekly change | +63.0% (Nov 22, 2023) |
| Weeks tracked | 235 |
| Tracking since | Feb 23, 2022 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.2146 per EA (NDC 68462087801), effective Aug 19, 2026.
How has the price of BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB changed over time?
Over the history we have for it, the NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB has declined 35.1%. It has been tracked across 235 weekly CMS publications since Feb 23, 2022.
What are the highest and lowest recorded NADAC prices for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB?
Since Feb 23, 2022, the NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB has ranged from a low of $0.1729 (Nov 20, 2024) to a high of $0.3901 (May 11, 2022), with a median of $0.2370 per EA.
Are there cheaper alternatives to BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB, is $0.2138 per EA — about 0% below BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB.
Who manufactures BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB?
BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB (NDC 68462087801) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.